X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Abbott India with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ABBOTT INDIA    Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ABBOTT INDIA   ADCOCK INGRAM
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-18
ADCOCK INGRAM
Jun-14
ABBOTT INDIA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs6,110368-   
Low Rs3,996265-   
Sales per share (Unadj.) Rs1,552.2109.3-  
Earnings per share (Unadj.) Rs188.8-27.6-  
Cash flow per share (Unadj.) Rs196.4-22.8-  
Dividends per share (Unadj.) Rs55.000-  
Dividend yield (eoy) %1.10-  
Book value per share (Unadj.) Rs796.685.8-  
Shares outstanding (eoy) m21.25168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.32.9 112.5%   
Avg P/E ratio x26.8-11.5 -233.1%  
P/CF ratio (eoy) x25.7-13.9 -185.7%  
Price / Book Value ratio x6.33.7 172.1%  
Dividend payout %29.10-   
Avg Mkt Cap Rs m107,37653,397 201.1%   
No. of employees `0003.34.3 77.4%   
Total wages/salary Rs m3,9373,351 117.5%   
Avg. sales/employee Rs Th9,929.34,298.8 231.0%   
Avg. wages/employee Rs Th1,185.1780.6 151.8%   
Avg. net profit/employee Rs Th1,207.7-1,083.2 -111.5%   
INCOME DATA
Net Sales Rs m32,98518,455 178.7%  
Other income Rs m1,170129 905.3%   
Total revenues Rs m34,15518,584 183.8%   
Gross profit Rs m5,245-3,198 -164.0%  
Depreciation Rs m162796 20.3%   
Interest Rs m38500 7.6%   
Profit before tax Rs m6,215-4,365 -142.4%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,203273 807.5%   
Profit after tax Rs m4,012-4,650 -86.3%  
Gross profit margin %15.9-17.3 -91.8%  
Effective tax rate %35.4-6.2 -567.2%   
Net profit margin %12.2-25.2 -48.3%  
BALANCE SHEET DATA
Current assets Rs m22,65513,517 167.6%   
Current liabilities Rs m6,6817,605 87.8%   
Net working cap to sales %48.432.0 151.2%  
Current ratio x3.41.8 190.8%  
Inventory Days Days65111 58.4%  
Debtors Days Days29124 23.5%  
Net fixed assets Rs m8357,879 10.6%   
Share capital Rs m21386 248.0%   
"Free" reserves Rs m16,7150-   
Net worth Rs m16,92814,485 116.9%   
Long term debt Rs m05,090 0.0%   
Total assets Rs m24,16227,363 88.3%  
Interest coverage x163.7-7.7 -2,117.0%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x1.40.7 202.4%   
Return on assets %16.8-15.2 -110.5%  
Return on equity %23.7-32.1 -73.8%  
Return on capital %36.9-19.8 -186.5%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-3,4380-   
CASH FLOW
From Operations Rs m1,5271,575 96.9%  
From Investments Rs m-2,148-484 444.2%  
From Financial Activity Rs m-1,0244,620 -22.2%  
Net Cashflow Rs m-1,6465,711 -28.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.07 Rs / ZAR

Compare ABBOTT INDIA With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare ABBOTT INDIA With: STERLING BIOTECH  NATCO PHARMA  GSK PHARMA  STRIDES PHARMA SCIENCE  UNICHEM LAB  



Today's Market

Sensex Opens Flat; Metal & Capital Goods' Stocks Lag(09:30 am)

Asian stock markets finished mixed as of the most recent closing prices. The Hang Seng gained 0.4% and the Nikkei 225 rose 0.2%.

Related Views On News

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (2QFY19); Net Profit Up 0.1% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 0.1% YoY). Sales on the other hand came in at Rs 10 bn (up 5.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

The One Real Estate Stock to Buy Now(The 5 Minute Wrapup)

Feb 13, 2019

The real estate sector is ready to make a comeback. This is the stock to consider buying.

Don't Be Afraid of the Market; Buy Stocks Like This One(The 5 Minute Wrapup)

Feb 14, 2019

During this tough period in the market, a contrarian approach holds huge potential upside for this Smart Money Secrets stock.

Small Caps Under Seige: Could This Be A Once-in-a-Decade Wealth Creating Opportunity?(Profit Hunter)

Feb 14, 2019

Don't let the dark clouds hovering over small caps scare you into hiding; it will rain gold as sentiments recover. Indeed, there is a blood bath. And if you are a first time investor, the correction is deep enough to scare you out of markets.

The 4-Point Plan to Accelerate India to a 10 Trillion Dollar Economy(The 5 Minute Wrapup)

Feb 12, 2019

Two questions I have been eagerly waiting to ask you ever since Budget 2019 was announced.

The Train to 'Small-Cap-Profits Land' is Back on the Station!(Profit Hunter)

Feb 15, 2019

Why its great news that prices for small caps over the last few days have been falling like there's no tomorrow.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Feb 22, 2019 10:15 AM

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA - DR. DATSONS LABS COMPARISON

COMPARE ABBOTT INDIA WITH

MARKET STATS